What is the next step in management for a patient with thyroid biopsy results showing macrophages only?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Thyroid Biopsy Showing Only Macrophages

Repeat the fine-needle aspiration biopsy (FNAB) immediately, as a specimen containing only macrophages is nondiagnostic and inadequate for clinical decision-making. 1

Understanding the Result

A thyroid biopsy showing only macrophages represents an inadequate/nondiagnostic specimen that cannot exclude malignancy or provide meaningful diagnostic information. 2, 3

  • Macrophages are commonly seen in thyroid nodules with cystic degeneration or hemorrhagic change, but their presence alone does not constitute an adequate sample for diagnosis. 2
  • Histiocytic aggregates can occasionally mimic features of papillary thyroid carcinoma with nuclear grooves and chromatin clearing, but without follicular cells present, no definitive diagnosis can be made. 2
  • The presence of only macrophages after two biopsies suggests either technical sampling issues or a predominantly cystic lesion. 3

Immediate Next Steps

Repeat FNAB with Optimized Technique

Perform a third FNAB using improved sampling technique to obtain diagnostic follicular cells. 1, 3

  • Target solid components of the nodule under ultrasound guidance, avoiding cystic or hemorrhagic areas where macrophages predominate. 3
  • Consider using a whirling technique rather than to-and-fro motion if the nodule contains calcifications or fibrotic areas, as this may improve specimen adequacy. 4
  • Ensure on-site cytology evaluation if available to confirm specimen adequacy before completing the procedure. 3

Consider Core Needle Biopsy (CNB)

If a third FNAB remains nondiagnostic, proceed to core needle biopsy, which has superior diagnostic performance in challenging nodules. 3, 4

  • CNB demonstrates significantly lower unsatisfactory rates compared to FNAB (3.7% vs. 33.3%) in difficult-to-sample nodules. 4
  • This approach is particularly valuable for nodules with extensive calcification, fibrosis, or predominantly cystic architecture. 3, 4

Risk Stratification During Workup

Ultrasound Re-evaluation

Perform dedicated thyroid ultrasound to assess features that determine urgency and guide sampling strategy. 5

  • High-risk features requiring aggressive pursuit of diagnosis include: microcalcifications, solid hypoechoic composition, taller-than-wide shape, irregular margins, and central vascularity. 5, 3
  • Evaluate for suspicious cervical lymph nodes, which would mandate definitive tissue diagnosis regardless of nodule size. 5
  • Nodules ≥1-1.5 cm with suspicious features warrant persistent attempts at diagnosis. 5

TSH Measurement

Obtain TSH level if not already done to identify hyperfunctioning nodules that require different management. 5

  • Hyperfunctioning ("hot") nodules on thyroid scintigraphy have extremely low malignancy risk and may not require further biopsy attempts. 5

Common Pitfalls to Avoid

  • Do not accept a nondiagnostic result as reassuring. Two inadequate biopsies do not exclude malignancy and should not delay further diagnostic efforts. 1
  • Do not assume cystic nodules are benign. Papillary thyroid carcinoma frequently undergoes cystic degeneration, and macrophage-rich aspirates may represent sampling of the cystic component rather than the solid tumor. 2
  • Do not perform molecular testing on macrophage-only specimens. Molecular markers require follicular epithelial cells and cannot be interpreted from histiocytes alone. 1
  • Avoid sampling only the cystic portion. Direct the needle specifically toward any solid components visible on ultrasound. 3

If Diagnosis Remains Elusive

For nodules with persistently nondiagnostic cytology despite optimized technique and CNB, management depends on ultrasound risk stratification. 5

  • High-suspicion nodules: Consider diagnostic surgical excision (lobectomy) given the significant malignancy risk despite nondiagnostic biopsies. 1
  • Low-suspicion nodules <1 cm: May be followed with serial ultrasound at 6-12 month intervals if clinical risk factors are absent. 1, 5
  • Intermediate-suspicion nodules: Repeat ultrasound in 3-6 months; if growth or development of high-risk features occurs, proceed to surgical excision. 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The thyroid: review of imaging features and biopsy techniques with radiologic-pathologic correlation.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2014

Guideline

Management of Incidental Thyroid Mass

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.